InspireMD (NSPR) EBIT Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 96.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 96.01% |
| Sep 30, 2025 | -41.46% |
| Jun 30, 2025 | -40.63% |
| Mar 31, 2025 | -36.70% |
| Dec 31, 2024 | 85.98% |
| Sep 30, 2024 | -28.04% |
| Jun 30, 2024 | -33.91% |
| Mar 31, 2024 | -30.79% |
| Dec 31, 2023 | -16.03% |
| Sep 30, 2023 | -36.96% |
| Jun 30, 2023 | -29.52% |
| Mar 31, 2023 | -29.42% |
| Dec 31, 2022 | -25.35% |
| Sep 30, 2022 | -32.16% |
| Jun 30, 2022 | -28.95% |
| Mar 31, 2022 | -12.75% |
| Dec 31, 2021 | -21.24% |
| Sep 30, 2021 | -26.76% |
| Jun 30, 2021 | -32.67% |
| Mar 31, 2021 | -19.28% |
| Dec 31, 2020 | -36.90% |
| Sep 30, 2020 | -1.73% |
| Jun 30, 2020 | -2.16% |
| Mar 31, 2020 | 5.62% |
| Dec 31, 2019 | -6.17% |
| Sep 30, 2019 | -4.34% |
| Jun 30, 2019 | -7.32% |
| Mar 31, 2019 | -15.53% |
| Dec 31, 2018 | 5.46% |
| Sep 30, 2018 | 16.60% |
| Jun 30, 2018 | 25.57% |
| Mar 31, 2017 | 24.27% |
| Sep 30, 2016 | 23.23% |
| Jun 30, 2016 | 25.17% |
| Mar 31, 2016 | 14.17% |
| Dec 31, 2015 | 15.75% |
| Sep 30, 2015 | -1.30% |
| Mar 31, 2014 | -67.87% |
| Sep 30, 2013 | -75.64% |
| Jun 30, 2013 | -82.89% |